ETFsiBoxx MSCI ESG EUR FRN Investment Grade Corporates TCA TRI
Amundi

Amundi EUR Floating Rate Corporate Bond ESG UCITS ETF Acc

AFRN PAAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
113.50EUR
+0.07% · +€0.08
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
AFRNBase
Fund charges
0.18%Total expense ratio (TER)
Fund size
€1.5bnall share classes
Return 1Y
+2.5%
Sharpe 3Y
0.93
Volatility 1Y
0.4%annualised
Holdings
141Fund holdings

Performance

Compare
  • AFRN+2.5%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
AFRN+0.2%+0.6%+1.3%+2.0%+2.5%+10.3%+12.8%
MSCI World+0.4%+4.9%+10.8%+16.3%+15.9%+75.5%+71.2%
Gap to MSCI World-0.3%-4.2%-9.5%-14.3%-13.4%-65.2%-58.5%

Risk and return

Sharpe ratio · 3Y
0.93
Below MSCI World · 1.24
Return p.a.
+3.3%
Volatility
0.5%
Max loss
-0.5%Dec 2023

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
AFRN
0.93
CAC 40
0.37
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
13.5%
Holdings
141
As of
Fund holdings
  1. 1AUST & NZ BAN FRN May27 EMTNXS28225252051.55%
  2. 2COOPERATIEVE FRN Jul28XS28609468671.52%
  3. 3JPMORGAN CHAS FRN Feb29 EMTNXS33003493991.51%
  4. 4NATWEST MARKE FRN Jun28 EMTNXS30910380781.32%
  5. 5WESTPAC BANKI FRN Jan28 EMTNXS29762831301.29%
  6. 6UBS GROUP FRN May29 EMTNCH14332411921.29%
  7. 7AUST & NZ BAN FRN Oct27 EMTNXS29867208161.27%
  8. 8ING BANK NV FRN May28XS33717182661.25%
  9. 9SOCIETE GENER FRN Jul28 EMTNFR0014019PT21.24%
  10. 10BARCLAYS BK P FRN Jun28XS34056749801.22%

Countries

Classified 100.0%
Largest
18.8%United States
Top 3
47.1%
Effective number
9.61 / HHI

Market cap

Weight vs holdings

13.5%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-141

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.